Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.

[1]  S. Abraham,et al.  Mast cells as modulators of host defense in the lung. , 1997, Frontiers in bioscience : a journal and virtual library.

[2]  T. Sun,et al.  In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[5]  R. Hodges,et al.  Structure-function analysis of the adherence-binding domain on the pilin of Pseudomonas aeruginosa strains PAK and KB7. , 1995, Biochemistry.

[6]  M. Byström,et al.  Carbohydrate specificity of the Escherichia coli P-pilus papG protein is mediated by its N-terminal part. , 1995, Biochimica et biophysica acta.

[7]  Z. Xu,et al.  Molecular dissection of PapD interaction with PapG reveals two chaperone‐binding sites , 1995, Molecular microbiology.

[8]  J. Pinkner,et al.  FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Xia,et al.  Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. , 1995, The Journal of clinical investigation.

[10]  E. Nurmiaho-Lassila,et al.  The Escherichia coli G-fimbrial lectin protein participates both in fimbrial biogenesis and in recognition of the receptor N-acetyl-D-glucosamine , 1995, Journal of bacteriology.

[11]  S. Normark,et al.  The amino‐terminal domain of the P‐pilus adhesin determines receptor specificity , 1994, Molecular microbiology.

[12]  S. Abraham,et al.  Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. , 1994, The Journal of clinical investigation.

[13]  S. Clegg,et al.  Type 1 fimbrial shafts of Escherichia coli and Klebsiella pneumoniae influence sugar-binding specificities of their FimH adhesins , 1994, Infection and immunity.

[14]  R. Hodges,et al.  The binding of Pseudomonas aeruginosa pili to glycosphingolipids is a tip‐associated event involving the C‐terminal region of the structural pilin subunit , 1994, Molecular microbiology.

[15]  J. Pinkner,et al.  FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Bloch,et al.  Enhanced virulence of Escherichia coli bearing a site-targeted mutation in the major structural subunit of type 1 fimbriae , 1993, Infection and immunity.

[17]  S. Hultgren,et al.  Neutrophil activation by nascent FimH subunits of type 1 fimbriae purified from the periplasm of Escherichia coli. , 1993, The Journal of biological chemistry.

[18]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[19]  C. Svanborg,et al.  Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring , 1991, Infection and immunity.

[20]  T. Bühler,et al.  Analysis of colonization factor antigen I, an adhesin of enterotoxigenic Escherichia coli O78:H11: fimbrial morphology and location of the receptor-binding site , 1991, Infection and immunity.

[21]  R. Endres,et al.  Fragmentation of Escherichia coli type 1 fimbriae exposes cryptic D-mannose-binding sites , 1991, Journal of bacteriology.

[22]  T. Patterson,et al.  Epidemiology, natural history, and management of urinary tract infections in pregnancy. , 1991, The Medical clinics of North America.

[23]  D. Nash,et al.  Urinary tract infection: economic considerations. , 1991, The Medical clinics of North America.

[24]  E. Parr,et al.  Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). , 1991, Vaccine.

[25]  J. R. Johnson,et al.  Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.

[26]  S. Harris,et al.  Isolation and characterization of mutants with lesions affecting pellicle formation and erythrocyte agglutination by type 1 piliated Escherichia coli , 1990, Journal of bacteriology.

[27]  E. Dodson,et al.  The structure of the saccharide‐binding site of concanavalin A. , 1989, The EMBO journal.

[28]  D. Low,et al.  Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains. , 1989, The Journal of clinical investigation.

[29]  S. Clegg,et al.  Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae , 1989, Journal of bacteriology.

[30]  E. Beachey,et al.  Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae , 1988, Nature.

[31]  S. Clegg,et al.  Characterization of two genes encoding antigenically distinct type-1 fimbriae of Klebsiella pneumoniae. , 1988, Gene.

[32]  N. Topley,et al.  Type 1 fimbriate Escherichia coli stimulates a unique pattern of degranulation by human polymorphonuclear leukocytes , 1988, Infection and immunity.

[33]  R. Ezekowitz,et al.  A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins [published erratum appears in J Exp Med 1991 Sep 1;174(3):753] , 1988, The Journal of experimental medicine.

[34]  E. Beachey,et al.  Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products , 1987, Journal of bacteriology.

[35]  F. K. Graaf,et al.  The role of lysine‐132 and arginine‐136 in the receptor‐binding domain of the K99 fibrillar subunit. , 1987, The EMBO journal.

[36]  E. Beachey,et al.  Assembly of a chemically synthesized peptide of Escherichia coli type 1 fimbriae into fimbria-like antigenic structures , 1987, Journal of bacteriology.

[37]  J. Sobel,et al.  Bacterial adherence in the pathogenesis of urinary tract infection: a review. , 1987, Reviews of infectious diseases.

[38]  H. van Pelt-Heerschap,et al.  Inhibition of adhesive activity of K88 fibrillae by peptides derived from the K88 adhesin , 1987, Journal of bacteriology.

[39]  L. Maurer,et al.  Identification and characterization of genes determining receptor binding and pilus length of Escherichia coli type 1 pili , 1987, Journal of bacteriology.

[40]  L. Maurer,et al.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli , 1986, Infection and immunity.

[41]  J. Seyer,et al.  Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. , 1986, Journal of immunology.

[42]  E. Beachey,et al.  The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit , 1986, Journal of bacteriology.

[43]  R. Adegbola,et al.  Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy. , 1985, Journal of medical microbiology.

[44]  W. Simpson,et al.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors , 1985, Infection and immunity.

[45]  G. Schoolnik,et al.  Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. , 1985, The Journal of clinical investigation.

[46]  S. Falkow,et al.  Organization and expression of genes responsible for type 1 piliation in Escherichia coli , 1984, Journal of bacteriology.

[47]  L. Bjursten,et al.  Influence of adhesins on the interaction of Escherichia coli with human phagocytes , 1984, Infection and immunity.

[48]  P. René,et al.  Serum and urogenital antibody responses to Escherichia coli pili in cystitis , 1982, Infection and immunity.

[49]  I. Mattsby‐Baltzer,et al.  Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli , 1982, Infection and immunity.

[50]  L. Hagberg,et al.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections , 1981, Infection and immunity.

[51]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[52]  F. Silverblatt,et al.  Antipili antibody affords protection against experimental ascending pyelonephritis. , 1979, The Journal of clinical investigation.

[53]  S. Glabman,et al.  PERSISTENT IMMUNOGLOBULINURIA IN IRREVERSIBLE RENAL ALLOGRAFT REJECTION IN HUMANS , 1977, Transplantation.

[54]  J. Holmgren,et al.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization , 1975, Infection and immunity.

[55]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[56]  W. Keane,et al.  Experimental pyelonephritis. XIV. Pyelonephritis in normal mice produced by inoculation of E. coli into the bladder lumen during water diuresis. , 1967, The Yale journal of biology and medicine.

[57]  M. Turner,et al.  Antibodies of IgA and IgG class in normal human urine. , 1967, Immunology.

[58]  C. Brinton.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria. , 1965, Transactions of the New York Academy of Sciences.

[59]  R. Isberg,et al.  Isolation and identification of eukaryotic receptors promoting bacterial internalization. , 1994, Methods in enzymology.

[60]  S. Hultgren,et al.  Chaperone-assisted assembly and molecular architecture of adhesive pili. , 1991, Annual review of microbiology.

[61]  S. Ma.  Synthetic peptides: prospects for a pili (fimbriae)-based synthetic vaccine. , 1990, Current topics in microbiology and immunology.

[62]  R. Adegbola,et al.  Antigenic relationships among type-1 fimbriae of Enterobacteriaceae revealed by immuno-electronmicroscopy. , 1987, Journal of medical microbiology.

[63]  P. de Man,et al.  Bacterial virulence in urinary tract infection. , 1987, Infectious disease clinics of North America.

[64]  R. Weinstein,et al.  Protection against experimental pyelonephritis by antibodies to pili. , 1982, Scandinavian journal of infectious diseases. Supplementum.

[65]  M. Levine,et al.  Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. , 1982, Scandinavian journal of infectious diseases. Supplementum.